Claims for Patent: 12,138,278

Summary for Patent: 12,138,278

Title:	Topical compositions
Abstract:	The disclosure provides a topical gel formulation comprising 1-1.5 wt. % clindamycin phosphate, 2.5-3.5 wt. % benzoyl peroxide, and 0.1-0.2 wt. % adapalene, in combination with a gelling agent, a polyhydric alcohol, and water, useful in treating inflammatory skin conditions, including acne, together with methods of making and using the same.
Inventor(s):	Varsha Bhatt, Radhakrishnan Pillai, Arturo Angel
Assignee:	Bausch Health Ireland Ltd
Application Number:	US18/639,630
Patent Claims:	1. A topical gel formulation comprising: 1-1.5 wt. % clindamycin phosphate; 2.5-3.5 wt. % benzoyl peroxide; about 0.15-0.2 wt. % adapalene; a gelling agent; an additional agent as a polyhydric alcohol; and water, wherein the ratio by weight of water to polyhydric alcohol in the formulation is 10:1 to 20:1, respectively, and the formulation is stable at room temperature for at least six weeks. 2. The topical gel formulation of claim 1, wherein the formulation is stable at a temperature of, or below 77° F., for at least six weeks. 3. The topical gel formulation of claim 1, wherein the concentration of clindamycin phosphate is about 1.2 wt. %, the concentration of benzoyl peroxide is about 3.1 wt. %, and the concentration of adapalene is 0.15 wt. %. 4. The topical gel formulation of claim 3, wherein the polyhydric alcohol is propylene glycol in a concentration of about 5 wt. %, the gelling agent is carbomer homopolymer Type C in a concentration of about 1.75 wt. %, the formulation further comprising potassium hydroxide in an amount to provide a pH of 5-6. 5. The topical gel formulation of claim 1, wherein the formulation is stable when refrigerated at 36° F. to 46° F. 6. The topical gel formulation of claim 1, wherein the formulation is stable at room temperature for at least ten weeks. 7. The topical gel formulation of claim 1, wherein the formulation is stable at a temperature of, or below 770° F. 8. The topical gel formulation of claim 1, wherein the gelling agent is selected from the group consisting of hydroxypropylcellulose, hydroxyethylcellulose, carboxyvinyl polymers, carboxyvinyl polymers crosslinked with allyl ethers of polyalcohols, carboxyvinyl copolymers, polyacrylates, acrylate copolymers, acrylamide/sodium acryloyldimethyltaurate copolymers, polyvinyl alcohols, polyethylene oxides, propylene glycol alginates, methylcellulose, hydroxypropylmethylcellulose, xanthan gum, carrageenan gum, and combinations thereof. 9. The topical gel formulation of claim 1, wherein the gelling agent comprises carbomer homopolymer Type C. 10. The topical gel formulation of claim 1, wherein the gelling agent is a crosslinked polymer comprising carboxy moieties and wherein the formulation further comprises a base selected from the group consisting of potassium hydroxide, sodium hydroxide and combinations thereof in an amount sufficient to deprotonate the carboxy moieties sufficiently to cause the gelling agent to thicken. 11. The topical gel formulation of claim 1, wherein the amount of gelling agent is 1.5 wt. % to 2 wt. %. 12. The topical gel formulation of claim 1, wherein an undissolved fraction of the benzoyl peroxide comprises a plurality of benzoyl peroxide particles having a mean particle size between 1 and 50 microns. 13. The topical gel formulation of claim 1, wherein a fraction of the adapalene is undissolved and wherein the undissolved fraction of the adapalene is homogeneously dispersed in the formulation. 14. The topical gel formulation of claim 1, wherein the adapalene and the benzoyl peroxide do not undergo any detrimental interaction with one another. 15. The topical gel formulation of claim 1, wherein the polyhydric alcohol is selected from the group consisting of propylene glycol, ethoxydiglycol, polyethylene glycol, and glycerol. 16. The topical gel formulation of claim 1, wherein the formulation is free of additional agents as organic solvents other than the polyhydric alcohol. 17. The topical gel formulation of claim 1, wherein the amount of polyhydric alcohol is 3 wt. % to 7 wt. %. 18. The topical gel formulation of claim 1, wherein the formulation is free of ionic surfactants. 19. The topical gel formulation of claim 1, wherein the benzoyl peroxide is not encapsulated or entrained in a microsponge. 20. The topical gel formulation of claim 1, wherein the formulation is free of preservatives other than the polyhydric alcohol.